A Phase 4 interventional study of Aminolevan EN and Placebo in Liver Disease, sponsored by Kochi University. Completed at 1 site in Japan. Per ClinicalTrials.gov, last updated 2008-04-14.
Sponsored by Kochi University · Phase 4, Interventional, and Health services research
To elucidate the effect of preoperative supplementation of carbohydrate and branched-chain amino acids on postoperative insulin resistance in patients undergoing hepatic resection, we set a randomized trial.
Twenty-six patients with hepatectomy due to a live tumor were prospectively randomized to receive a preoperative supplementation with carbohydrate and branched-chain amino acids-enriched nutrient or not.
2,081 studies on the registry are indexed under Liver Diseases; 390 are open to participants now.
This study's enrollment of 26 is below the median of 50 across 1,323 interventional studies indexed under Liver Diseases.
Browse Liver Diseases studies →Kochi University is the lead sponsor of 18 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
receive a preoperative supplementation with carbohydrate and branched-chain amino acids-enriched nutrient
Dietary Supplement: Aminolevan EN
receive a preoperative supplementation without carbohydrate and branched-chain amino acids-enriched nutrient
Dietary Supplement: Placebo
The present study used carbohydrate and BCAA-enriched soft-powder nutrient-mixture for preoperative supplementation. Supplementation with Aminolevan EN (100 g per day) started at two weeks prior to the surgery under the careful monitoring of compliance.
placebo
Also known as: No receive, normal diet
to evaluate the total amount of insulin required for glycemic control after hepatic resection
Time frame: total amount of insulin required
to investigate the trends of postoperative blood glucose levels and the incidence of severe hypoglycemia (< 40 mg/dL) by using artificial pancreas during intensive care unit stay
Time frame: hypoglycemia
This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kochi University